Gapping up
In reaction to strong earnings/guidance: TACO +13.6%, TTS +10.7%, SONC +5.7%, IHG +5.5%, GIG +4.3%, HSTM +3.7%, FLEX +3.1%, CE +1.6%, VZ +1.6%, SAP +1.5%, VLRS +0.8%, TRV +0.6%
M&A news: TMH +21.9% (AmSurg (AMSG) confirms proposal to acquire TeamHealth for $71.47/share, or ~$7.8 bln), SNDK +8.7% (Bloomberg reporting co is in discussion to be acquired by Western Digital (WDC)), YUM +6% (to separate into two publicly traded companies; China Division to become independent company focused on growth in Mainland China)
Select metals/mining stocks trading higher: AU +3.1%, IAG +2.1%, GOLD +2%, ABX +1.6%, GDX +1.4%, GG +1.3%, SLW +1.1%
Other news: ERII +135% (signed 15-year license with Schlumberger (SLB) to provide exclusive rights to its VorTeq hydraulic fracturing technology; deal includes $125 mln in upfront payments paid in stages), ONE +42.5% (sold its Campus Labs data analytics business to Leeds Equity Partners, for $91 mln in cash), CRBP +34.1% (confirms the FDA has granted a Fast Track development program and Orphan Drug Designation for Resunab, to treat cystic fibrosis), RXII +10.8% (reports positive results with its RNAi platform, showing it demonstrated robust and potent reduction of the levels of lncRNAs in a target specific manner), KITE +3.5% (enters into an exclusive, worldwide license with the National Institutes of Health, related to T Cell Receptor-based product candidates), ATRA +1.9% (confirms Orphan Drug Designation from the FDA, for STM 434 to treat ovarian cancer), SKX +1.7% (still checking), MPAA +1.6% (to replace OMG in the S&P SmallCap 600)
Analyst comments: RCPI +8.4% (initiated with a Buy at Maxim Group; tgt $4), WTW +6.1% (upgraded to Equal Weight from Underweight at Barclays), TSEM +5.1% (initiated with a Buy at Drexel Hamilton), RESN +3.1% (initiated with a Buy at Drexel Hamilton), BLUE +2.3% (initiated with an Outperform at Oppenheimer; $162 tgt), GOLD +2% (upgraded to Buy from Hold at Deutsche Bank), CPE +1.7% (initiated with a Buy at Canaccord Genuity), ADRO +0.7% (initiated with an Outperform at Oppenheimer), PFE +0.7% (upgraded to Outperform from Market Perform at Cowen
)
In reaction to strong earnings/guidance: TACO +13.6%, TTS +10.7%, SONC +5.7%, IHG +5.5%, GIG +4.3%, HSTM +3.7%, FLEX +3.1%, CE +1.6%, VZ +1.6%, SAP +1.5%, VLRS +0.8%, TRV +0.6%
M&A news: TMH +21.9% (AmSurg (AMSG) confirms proposal to acquire TeamHealth for $71.47/share, or ~$7.8 bln), SNDK +8.7% (Bloomberg reporting co is in discussion to be acquired by Western Digital (WDC)), YUM +6% (to separate into two publicly traded companies; China Division to become independent company focused on growth in Mainland China)
Select metals/mining stocks trading higher: AU +3.1%, IAG +2.1%, GOLD +2%, ABX +1.6%, GDX +1.4%, GG +1.3%, SLW +1.1%
Other news: ERII +135% (signed 15-year license with Schlumberger (SLB) to provide exclusive rights to its VorTeq hydraulic fracturing technology; deal includes $125 mln in upfront payments paid in stages), ONE +42.5% (sold its Campus Labs data analytics business to Leeds Equity Partners, for $91 mln in cash), CRBP +34.1% (confirms the FDA has granted a Fast Track development program and Orphan Drug Designation for Resunab, to treat cystic fibrosis), RXII +10.8% (reports positive results with its RNAi platform, showing it demonstrated robust and potent reduction of the levels of lncRNAs in a target specific manner), KITE +3.5% (enters into an exclusive, worldwide license with the National Institutes of Health, related to T Cell Receptor-based product candidates), ATRA +1.9% (confirms Orphan Drug Designation from the FDA, for STM 434 to treat ovarian cancer), SKX +1.7% (still checking), MPAA +1.6% (to replace OMG in the S&P SmallCap 600)
Analyst comments: RCPI +8.4% (initiated with a Buy at Maxim Group; tgt $4), WTW +6.1% (upgraded to Equal Weight from Underweight at Barclays), TSEM +5.1% (initiated with a Buy at Drexel Hamilton), RESN +3.1% (initiated with a Buy at Drexel Hamilton), BLUE +2.3% (initiated with an Outperform at Oppenheimer; $162 tgt), GOLD +2% (upgraded to Buy from Hold at Deutsche Bank), CPE +1.7% (initiated with a Buy at Canaccord Genuity), ADRO +0.7% (initiated with an Outperform at Oppenheimer), PFE +0.7% (upgraded to Outperform from Market Perform at Cowen
)